Impact of Laboratory Characteristics and Staff Training and Credentials on MPI Accreditation Decisions
| Characteristic | Adjusted odds ratio |
| Number of sites | 1.01 (0.97–1.05) |
| Annual laboratory volume per 1,000 MPI studies | 1.06 (0.96–1.18) |
| Application cycle (per subsequent cycle) | 1.00 (0.91–1.11) |
| Consultant assistance with application | 1.94 (1.49–2.53) |
| Hospital facility | 1.08 (0.75–1.57) |
| Doing general nuclear medicine or PET oncology/neurology | 0.89 (0.58–1.37) |
| Medical director with CBNC status | 1.28 (1.03–1.58) |
| Cardiovascular pathway of medical director | 1.03 (0.82–1.29) |
| Medical director compliant with CME | 1.97 (1.53–2.54) |
| Volume of studies interpreted by medical director, quartiles | |
| 0–300 | Referent |
| 301–500 | 1.21 (0.92–1.60) |
| 501–900 | 1.03 (0.78–1.36) |
| 901+ | 0.75 (0.55–1.03) |
| Number of medical staff | 0.82 (0.75–0.89) |
| At least 50% of medical staff with CBNC | 1.06 (0.85–1.31) |
| Number of medical staff compliant with CE | 1.28 (1.16–1.42) |
| Technical director with NCT or PET vs. CNMT or RT(N) | 1.49 (1.06–2.10) |
| Technical director compliant with CE | 2.48 (1.86–3.31) |
| Number of technical staff | 0.91 (0.80–1.04) |
| Number of technical staff compliant with CE | 1.12 (0.97–1.29) |
95% confidence intervals are in parentheses.